Document is current

Any future updates will be listed below

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

Crossref DOI link: https://doi.org/10.1186/s13075-015-0611-8

Published Online: 2015-04-09

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark